Results 331 to 340 of about 2,632,133 (359)

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

Lancet, The, 2012
John Buse, Michel Marre, Lyudmila A Suplotova   +2 more
exaly  

Insulin/insulin aspart/insulin glargine

Reactions Weekly, 2014
openaire   +1 more source

Coated charcoal immunoassay of insulin.

Journal of Clinical Endocrinology and Metabolism, 1965
V. Herbert, K. Lau, C. Gottlieb, S. Bleicher   +3 more
semanticscholar   +1 more source

Insulin and insulin-like growth factor signalling in neoplasia

Nature Reviews Cancer, 2008
Michael N Pollak
exaly  

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

Lancet, The, 2012
Stefano Del Prato, Manuel Muñoz-Torres, Julio Rosenstock   +2 more
exaly  

Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin Sensitivity.

Cell, 2017
Wei Ying, Matthew Riopel, G. Bandyopadhyay, Yi Dong, A. Birmingham, Jong Bae Seo, Jachelle M. Ofrecio, Joshua Wollam, Angelina Hernandez-Carretero, Wenxian Fu, Pingping Li, J. Olefsky   +11 more
semanticscholar   +1 more source

Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study

Lancet, The, 2009
Adam G Tabak, Markus Jokela, Eric J Brunner   +2 more
exaly  

Insulin/insulin-suspension-isophane/insulin

Reactions Weekly, 2019
openaire   +1 more source

Insulin-aspart/insulin-glargine/insulin-lispro

Reactions Weekly, 2020
openaire   +1 more source

Insulin/insulin detemir/insulin suspension isophane

Reactions Weekly, 2012
openaire   +1 more source